What is the ticker symbol for CEL-SCI?

CEL-SCI trades under the ticker CVM on AMEX.

What sector does CEL-SCI operate in?

CEL-SCI is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CVM in a portfolio?

PortView shows CVM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

CEL-SCI (CVM) Stock Analysis

AMEXHealthcareBiotechnology

$1.61+0.00%

1-year price historyRange $0.97 – $11.83

52-week range$1.61

$0.89$12.68

What CEL-SCI does

CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is currently undergoing Phase III clinical trials for the treatment of head and neck cancer. The company also develops and holds the patent for its preclinical Ligand Epitope Antigen Presentation System (LEAPS), an innovative T-cell modulation technology. This system is designed to stimulate the human immune system to fight a broad range of conditions, including bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and various cancers. CEL-SCI's pipeline further includes LEAPS-H1N1-DC, along with LEAPS COV-19, an experimental therapy targeting the COVID-19 coronavirus. Additionally, the company is advancing CEL-2000 and CEL-4000 as potential treatments for rheumatoid arthritis. In a collaborative effort, CEL-SCI has partnered with the University of Georgia's Center for Vaccines and Immunology to progress the LEAPS COVID-19 immunotherapy. Established in 1983, the company's headquarters are located in Vienna, Virginia.

Key metrics

Market cap

$11.06M

P/E (TTM)

-0.30

EPS (TTM)

$-5.41

Beta

0.56

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.33

200-day avg

$3.40

52-week high

$12.68

52-week low

$0.89

CEO

Geert R. Kersten

ETFs linked to CVM

Broad-market and Healthcare sector ETFs an investor holding CEL-SCI is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CVM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CVM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for CEL-SCI?: CEL-SCI trades under the ticker CVM on AMEX.
Which exchange is CVM listed on?: CVM is listed on AMEX.
What sector does CEL-SCI operate in?: CEL-SCI is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CVM in a portfolio?: PortView shows CVM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.